[New standard: combination therapy for the treatment of dyslipidemia]

Herz. 2022 Jun;47(3):195. doi: 10.1007/s00059-022-05117-7. Epub 2022 Jun 10.
[Article in German]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Combined Modality Therapy
  • Drug Therapy, Combination
  • Dyslipidemias* / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hypolipidemic Agents / therapeutic use

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents